Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Anticancer Research

• Publication date

  1997-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 9252720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

  2004cited by this paper
• Lung cancer

  1995cited by this paper
• Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

  1994cited by this paper
• Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

  1994cited by this paper
• Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer.

  1993cited by this paper
• Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma

  1993cited by this paper
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

  1993cited by this paper
• Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

  1992cited by this paper
• Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.

  1992cited by this paper
• Relation of neovascularisation to metastasis of non-small-cell lung cancer.

  1992cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

  1990cited by this paper
• Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

  1989cited by this paper
• Increasing incidence of adenocarcinoma of the lung

  1981cited by this paper

• Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma

  2023cites this paper
• Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.

  2015influential citation
• Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.

  2015cites this paper
• Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonary disease and lung cancer development in Chinese population.

  2014cites this paper
• Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues.

  2013cites this paper
• VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma

  2012cites this paper
• The controversial role of placental growth factor in tumor growth.

  2011cites this paper
• Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors.

  2011cites this paper
• Estudo de fatores prognósticos moleculares no carcinoma renal de células claras pela técnica de tissue microarray

  2011cites this paper
• Vascular Endothelial Growth Factor Expression and Microvascular Density in Soft Tissue Sarcomas in Dogs

  2010cites this paper
• Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity.

  2010cites this paper
• The Relatioships Between Tumor-related Gene Expression and Tumor Budding, Tumor Nodule and Lymph Node Extracapsular Extension in Colorectal Cancer

  2009cites this paper
• Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis

  2009cites this paper
• Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.

  2009cites this paper
• “Antimyeloangiogenic” Therapy for Cancer by Inhibiting PlGF

  2009cites this paper
• Functional MR imaging of the lung.

  2008cites this paper
• Relationship between expression of beta-catenin and VEGFs (VEGFA, VEGF-C), VEGF receptors-2 (VEGFR-2) in medulloblastoma

  2008cites this paper
• Angiogenesis Inhibitors for the Treatment of Lung Cancer

  2008cites this paper
• The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in non-small cell lung cancer.

  2007cites this paper
• A Comparison of Plasma Versus Histologic Indices of Angiogenic Markers in Breast Cancer

  2007cites this paper
• VEGF, VEGF-receptors and lung cancer

  2007cites this paper
• A Case of Pulmonary Thromboembolism Developed during Chemotherapy with Gemcitabine and Cisplatin for Nonsmall Cell Lung Cancer -A case report-

  2006cites this paper
• Phase I/Pilot Study of SU5416 (Semaxinib) in Combination With Irinotecan/Bolus 5-FU/LV (IFL) in Patients With Metastatic Colorectal Cancer

  2006cites this paper
• Vascular endocan is preferentially expressed in tumor endothelium.

  2006cites this paper
• [Vascular endothelial growth factor in benign and malignant pleural effusions].

  2005cites this paper
• El factor de crecimiento endotelial vascular en los derrames pleurales benignos y malignos

  2005cites this paper
• Cytokine targeted treatments for lung cancer.

  2005cites this paper
• Oxidative damage and counteracting mechanisms in breast carcinoma

  2005cites this paper
• Expression of vascular endothelial growth factor and its receptor, KDR/Flk-1, in soft tissue sarcomas.

  2005cites this paper
• All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.

  2004cites this paper
• Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.

  2004cites this paper
• Vascular Endothelial Growth Factor (VEGF) in Astrocytic Gliomas – A Prognostic Factor?

  2004cites this paper
• Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in small-cell and non-small-cell lung carcinomas.

  2004cites this paper
• Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.

  2004cites this paper
• Malignant Tumors of the Lung

  2004cites this paper
• Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?

  2004cites this paper
• Molecular and Cell Biology of Lung Carcinoma

  2004cites this paper
• EXPRESIÓN DE LOS FACTORES ANGIOGÉNICOS VEGF Y bFGF, Y DE LOS RECEPTORES Flt-1 Y FLK/ KDR EN LA NEOPLASIA INTRAEPITELIAL PROSTÁTICA

  2004cites this paper
• Tyrosine Kinase Inhibitors as Cancer Therapy

  2003cites this paper
• Molecular targets in the inhibition of angiogenesis

  2003cites this paper
• Oncogenic Receptor Tyrosine Kinases

  2003cites this paper
• Small peripheral pulmonary carcinomas evaluated with dynamic MR imaging: correlation with tumor vascularity and prognosis.

  2003cites this paper
• Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma

  2003cites this paper
• Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia.

  2003cites this paper
• Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome

  2002cites this paper
• Expression of metastasis-related genes in human epithelial ovarian tumors.

  2002cites this paper
• Contrast‐enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma

  2002cites this paper
• Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors.

  2002cites this paper
• [VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis].

  2002cites this paper
• Vascular endothelial growth factor: the key mediator in pleural effusion formation

  2002cites this paper
• A potential autocrine role for vascular endothelial growth factor in prostate cancer.

  2002cites this paper
• VEGF et survie des patients atteints d'un cancer pulmonaire

  2002cites this paper
• The intratumoral expression of vascular endothelial growth factor and interleukin‐8 associated with angiogenesis in nonsmall cell lung carcinoma patients

  2001cites this paper
• Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy.

  2001cites this paper
• Angiogenic proteins in the lungs of children after cavopulmonary anastomosis.

  2001cites this paper
• Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer

  2001cites this paper
• General aspects of anti-angiogenesis and cancer therapy

  2001cites this paper
• Angiogenic proteins in the lungs of children after cavopulmonary anastomosis

  2000cites this paper
• New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.

  2000cites this paper
• Tumor angiogenesis, macrophages, and cytokines.

  2000cites this paper
• Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

  2000cites this paper
• High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

  2000cites this paper
• Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

  2000cites this paper
• Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas.

  1999cites this paper
• Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.

  1999cites this paper
• Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N‐nitrosobis(2‐hydroxypropyl)amine in rats

  1999cites this paper
• Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.

  1999cites this paper
• Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural e V usions

  1999cites this paper
• Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.

  1999cites this paper
• Expression of vascular endothelial growth factor receptors in human prostate cancer.

  1999cites this paper
• Vascular endothelial growth factor in pleural fluid.

  1999cites this paper
• The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer

  1999cites this paper
• Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions

  1999cites this paper